Company intelligence / Profile preview

ExCell Bio

Shanghai, Shanghai, Chinaexcellbio.com ↗

Ownership: Private
Development stage: Commercial

Overview

Leading Chinese supplier of life science reagents and biopharmaceutical critical materials, with a focus on cell culture media, sera, and analytical kits. Products support biopharma R&D, cell/gene therapy development, stem cell industry applications, and scientific research. The company has over two decades of history in the sector. No clinical results as it does not develop therapeutics.

Modalities: Cell culture medium (including serum-free)Fetal bovine serumIdentification reagents (for cell and gene therapy research)Residue detection kits
Industry: Chemicals & Materials

Beyond the preview

Go deeper on ExCell Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ExCell Bio.

Explore the full profile